# Alec Nielsen

> Alec Nielsen is a seed investor at Asimov (Cambridge) backing Biotechnology and Biopharma. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Asimov](https://shizune.co/investors/profile/asimov-2)
- Location: Cambridge, United States
- Total investments: 6
- Last investment: May 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alec-nielsen/

Alec Nielsen is a seed investor at Asimov in Cambridge focused on Biotechnology and Biopharma. Alec Nielsen is the Founder & CEO at Asimov.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 83% |
| Biopharma | 2 | 33% |
| Medical | 1 | 17% |
| Robotics | 1 | 17% |
| Life Science | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 83% |
| Pre-Seed | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 4 | 67% |
| Germany | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lamin | Lamin Labs provides data infrastructure for biology that enables data scientists and engineers to collaborate on a single data layer for R&D teams of any size. They want to achieve for R&D data what git and GitHub did for code by integrating wet and dry laboratories, people and AI, knowledge and data, and siloed teams and organizations.Lamin Labs is headquartered in Munich, Bayern and was founded in 2022. |  | Seed | May 10, 2025 |  |
| General Proximity | General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine. | $16M | Seed | Jan 03, 2025 |  |
| Cache | Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again. |  | Seed | May 07, 2024 |  |
| Trilobio | Trilobio was created to improve synthetic biology and life science research processes by building robotic lab automation modules coupled with an "app store" to package and distribute lab protocols as code. The goal is to deploy fully automated labs that dramatically improve data quality and reproducibility. | $3M | Seed | Nov 29, 2023 |  |
| Trilobio | Trilobio was created to improve synthetic biology and life science research processes by building robotic lab automation modules coupled with an "app store" to package and distribute lab protocols as code. The goal is to deploy fully automated labs that dramatically improve data quality and reproducibility. | $3M | Pre-Seed | Nov 29, 2023 |  |
| LatchBio | LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enablingbiotech companies to find therapies faster and save on engineering. | $5M | Seed | Oct 01, 2021 |  |

6 of 6 investments shown.

## Co-investors
- [Juniper](https://shizune.co/investors/profile/climate-capital-bio) — VC Fund, 3 deals together
- [1517 Fund](https://shizune.co/investors/profile/1517-fund) — VC Fund, 2 deals together
- [Argon Ventures](https://shizune.co/investors/profile/argon-ventures) — VC Fund, 2 deals together
- [Fifty Years](https://shizune.co/investors/profile/fifty-years) — VC Fund, 2 deals together
- [Lowercarbon Capital](https://shizune.co/investors/profile/lowercarbon-capital) — VC Fund, 2 deals together
- [Nucleus Capital](https://shizune.co/investors/profile/nucleus-capital) — VC Fund, 2 deals together

## About Asimov

VC Fund · Boston, United States

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.

5 contacts available at Asimov.

| Name | Title | Profile |
| --- | --- | --- |
| Alec Nielsen | Founder & CEO | https://shizune.co/investors/profile/alec-nielsen |
| Christopher Voigt | Co-Founder | https://shizune.co/investors/profile/christopher-voigt-ee6e |
| Douglas Densmore | Founder | https://shizune.co/investors/profile/douglas-densmore-e04b |
| Kevin D. Smith | Head of Technology Development | https://shizune.co/investors/profile/kevin-d-smith |
| Raja Srinivas | Founder | https://shizune.co/investors/profile/raja-srinivas |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors](https://shizune.co/investors/biotechnology-angel-investors)
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Biotech Angel Investors in United States](https://shizune.co/investors/biotech-angel-investors-united-states)
- [Life Science Angel Investors](https://shizune.co/investors/life-science-angel-investors)
- [Biotechnology Angel Investors in Germany](https://shizune.co/investors/biotechnology-angel-investors-germany)
- [Biotech Angel Investors in Germany](https://shizune.co/investors/biotech-angel-investors-germany)

## FAQ

### What does Alec Nielsen invest in?

Alec Nielsen invests primarily in Biotechnology, Biopharma and Medical startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Alec Nielsen's check size?

Alec Nielsen typically joins rounds of $3M–$16M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Alec Nielsen participates in.

### When did Alec Nielsen last invest?

The most recent investment recorded for Alec Nielsen closed in May 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co